← Return to Hard Cases

Study · verified by the research team

Urothelial Carcinoma Associated with the Use of a Chinese Herb (Aristolochia fangchi)

Nortier JL, Martinez MCM, Schmeiser HH, Arlt VM, Bieler CA, Petein M, Depierreux MF, De Pauw L, Abramowicz D, Vereerstraeten P, Vanherweghem JL · 2000 · New England Journal of Medicine 342(23): 1686–1692

https://doi.org/10.1056/NEJM200006083422301

Follow-up of Belgian patients with kidney failure after slimming pills in which one herb had been replaced, through a manufacturing error, by nephrotoxic Aristolochia fangchi.

Study details

DesignClinical case series with histology and DNA-adduct analysis
Population39 patients with end-stage 'Chinese-herb nephropathy' undergoing prophylactic surgery
OutcomeUrothelial carcinoma
Finding18 of 39 (46%) had urothelial carcinoma; aristolochic-acid DNA adducts in all samples; risk rose with cumulative dose
LimitationsSingle centre; specific to a substitution error, not to correctly identified herbs
Certaintymoderate

Cited by (1)

Chapters (1)